Science 37

Los Angeles, United States Founded: 2014 • Age: 12 yrs Listed Acquired By eMed Technologies
Provider of a suite solution for clinical trials for researchers

About Science 37

Science 37 is a Healthcare company based in Los Angeles (United States) founded in 2014, and was acquired by eMed Technologies in January 2024. Provider of a suite solution for clinical trials for researchers. Science 37 has raised $106.5 million across 4 funding rounds from investors including Amgen, Novartis and PPD. Its chief executive, as recorded, is David Coman. Its website science37.com draws about 29 thousand monthly visits. Science 37 offers products and services including Metasite Platform and Patient Recruitment. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and IQVIA; 2 of its 3 listed competitors have raised funding.

Company details

Science 37 was founded in 2014 and is headquartered in Los Angeles, United States. Operations focus on the clinical trials sector, where end-to-end solutions are delivered to support researchers. A mobile platform enables patient participation, while tools like Metasite facilitate site-based data collection, trial management, and communication. Additional features include recruitment systems, patient enrollment processes, and virtualization for study design concepts.

Key Metrics
  • Total Equity Funding
    $106.5M (USD)

    in 4 rounds

  • Latest Funding Round
    $40M (USD), Series D

    Aug 2020

  • Investors
    Amgen

    & 11 more

  • Acquired by

Products & Services of Science 37

Science 37 offers a comprehensive portfolio of products and services, including Metasite Platform and Patient Recruitment.

Metasite Platform
Clinical Trial Platform

Enables remote clinical trials for broader patient access and data collection

Patient Recruitment
Recruitment Service

Facilitates diverse participant enrollment in clinical studies remotely

Apps and channels of Science 37

Science 37 publishes 1 mobile app with over 10K+ downloads.

Science 37 Clinical Research
Google Play Health & Fitness Everyone Free 10K+ downloads
Developer: Science 37, Inc.
View on Google Play

Funding Insights of Science 37

Science 37 has successfully raised a total of $106.5M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $106.5M
  • Total Rounds 4
  • Last Round Series D — $40M
  • First Round $6.5M

    (Oct 2015)

  • Investors Count 11

All 4 funding rounds of Science 37 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2020$40MSeries D–Lux Capital, Redmile Group
Apr 2017$29MSeries C–Glynn Capital
Oct 2016$31MSeries B–Redmile Group
Oct 2015$6.5MSeries A–dRx Capital, Lux Capital
Valuation history

12 investors in total: 12 institutional.

Investors in Science 37

Science 37 has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Novartis and PPD.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Seed and early-stage technology companies are funded by Lux Capital.
luxcapital.comMenlo Park, United States
Corporate backed venture capital fund investing in multiple sectors
gv.comMountain View, United States
Investments are directed toward early and late-stage tech companies.
glynncapital.comMenlo Park, United States
Life-Sciences focused Early stage Corporate VC Firm investing in the US
sanofiventures.comParis, France
Healthcare startups are funded by this corporate-backed venture capital entity.
lifesciventure.comNew York, United States
Early-stage investments in US Tech and Life Sciences are targeted.
drxcapital.comBasel, Switzerland
Operates as an employee-owned hedge fund focused on long/short equity strategies.
2007redmilegroup.comSan Francisco, United States
CRO providing diversified clinical development services
1985ppd.comWilmington, United States
R&D focused on manufacturing of drugs for multiple therapeutic areas
1996novartis.comBasel, Switzerland
Developer of pharmaceutical products for treating multiple diseases
1980amgen.comThousand Oaks, United States
Premium access

Investor details for Science 37

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Science 37

85 people are tracked at Science 37 (27 in leadership, 3 in board & advisors, 55 in team).

NameRoleGroup
David Coman
CEOLeadership
Sara Trepanier M.D.
Medical Director, Emergency MedicineLeadership
David Kudrow
Medical Director, NeurologyLeadership
Tyler Van Horn
VP, Corporate Strategy & Chief of StaffLeadership
Scott Arceri
Vice President, Strategic SolutionsLeadership
Mark Hanson
Senior Director, Strategic Business DevelopmentLeadership
Irena Lambridis
VP & Head, Quality Assurance & ComplianceLeadership
Austin Crafts
Director Of EngineeringLeadership
Joel Parks
Director: Cloud, Site Reliability Engineering And Release EngineeringLeadership
Leonard White
Director Of Data And Enterprise ApplicationsLeadership
Elizabeth Cleale
Senior Director, Human ResourcesLeadership
Alina Wherry (Dawson)
Director Of Clinical OperationsLeadership
Samisha Thomas-Hans
Senior Director, Real-world EvidenceLeadership
Dave Chen
Director Of TechnologyLeadership
Michael Biron
Senior Director, Strategic SolutionsLeadership
Mikolaj K.
Business PartnerLeadership
Jeffrey Golden
Senior Director Of Strategic SolutionsLeadership
Adam Noe
Director, Strategic SolutionsLeadership
Nicole Tinfo
Sr. Director, Clinical ResearchLeadership
Christiane Dinneen
Vice President Clinical OperationsLeadership

65 more people are available in the full profile.

Premium access

Complete people profiles for Science 37

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Science 37

5 dated milestones of Science 37 across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Science 37 is founded.
  2. Funding First funding round of $6.5M.
  3. Funding Latest funding round, Series D, of $40.0M.
  4. IPO Lists on the stock exchange (IPO).
  5. Exit Acquired by eMed Technologies.

Competitors of Science 37

Science 37 has 3 listed competitors in our database, 2 of them funded. They include Medidata, Verily and IQVIA.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
iqvia.com1982Durham, United States88,000
Clinical research and commercialization solutions are provided for healthcare.
Premium access

Detailed competitors of Science 37

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Science 37

The website of Science 37 (science37.com) receives about 29.3K visits a month.

  • Monthly visits
    29.3K

    ▲ 7.6% vs previous month

Similar websites

Websites whose visitors overlap most with Science 37. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
vaulthealth.com
100%
7.3K#3,108,379View details
medcitynews.com
82%
128.8K#363,034View details
cellandgene.com
cellandgene.com
68%
#1,018,368–
medidata.com
49%
87K#373,122View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Science 37 (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Science 37

Premium access

Complete news archive for Science 37

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Science 37

Science 37 was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Science 37 is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

David Coman is the CEO of Science 37, as recorded in our data.

Science 37 is a funded company, having raised a total of $106.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6.5M, raised on Oct 2015.

Science 37 was founded in 2014 and is headquartered in Los Angeles, United States. Operations focus on the clinical trials sector, where end-to-end solutions are delivered to support researchers. A mobile platform enables patient participation, while tools like Metasite facilitate site-based data collection, trial management, and communication. Additional features include recruitment systems, patient enrollment processes, and virtualization for study design concepts.

Science 37's top competitors include Medidata, Verily and IQVIA.

Science 37 offers Metasite Platform and Patient Recruitment.

Science 37 has 12 investors. Key investors include Amgen, Novartis, PPD, Mubadala, and eMed Technologies.

Yes. Science 37 was acquired by eMed Technologies in January 2024.

Yes. Science 37 publishes Science 37 Clinical Research, with over 10,000 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available